Johnson & Johnson's single-dose COVID-19 vaccine given emergency use approval in India


1 min read
Read later
Print
Share

Photo: AFP

New Delhi: Johnson & Johnson's single-dose COVID-19 vaccine has been given Emergency Use approval in India, Union Health minister Mansukh Mandaviya said on Saturday.

He said this will further boost the country's collective fight against the novel coronavirus infection.

"India expands its vaccine basket! Johnson and Johnson's single-dose COVID-19 vaccine is given approval for Emergency Use in India. Now India has five EUA vaccines. This will further boost our nation's collective fight against #COVID19," the minister tweeted.

The US-based pharmaceutical company had applied for Emergency Use Authorisation for its jab on Friday and was granted the approval the same day by the Drugs Controller General of India (DCGI).

The five vaccines granted Emergency Use Authorisation in India are Serum Institute's Covishield, Bharat Biotech's Covaxin, Russia's Sputnik V, Moderna and now Johnson & Johnson.

PTI

Add Comment
Related Topics

Get daily updates from Mathrubhumi.com

Newsletter
Youtube
Telegram
Disclaimer: Kindly avoid objectionable, derogatory, unlawful and lewd comments, while responding to reports. Such comments are punishable under cyber laws. Please keep away from personal attacks. The opinions expressed here are the personal opinions of readers and not that of Mathrubhumi.

IN CASE YOU MISSED IT
hospital

1 min

Digital health mission: Kerala records over 130 lakh ABHA IDs

Sep 24, 2023


KG George

2 min

Evening Brief | September 24, 2023 

Sep 24, 2023


Danish Ali

2 min

BJP MP's allegations baseless, narrative being set for 'lynching me': Danish Ali

Sep 24, 2023